Journals / Selçuk Tıp Dergisi / 2019 / Cilt: 35 - Sayı: 2

The Distribution of Kidney Tumors in Our Hospital, The Relationship Between Pathological Stage, Nuclear Grade and Tumor Diameter: Analysis of 140 Cases

Hastanemizdeki Böbrek Tümörlerinin Dağılımı, Patolojik Evre, Nükleer Derece ve Tümör Çapı İle İlişkisi: 140 Olgunun Analizi

Pages
105–112
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As in our study, in retrospective studies involving old ages and not enough sampling, tumor diameter may be used as an alternative prognostic factor for pathological staging in tumors with a stage above pT2.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The renal cell carcinoma (RCC), which is the most frequently seen malign renal tumor, consists of 2-4% of all the malign tumors seen among adult individuals and 80-90% of all the malign renal tumors.
📊
Key Findings & Data:The recurrence is seen in 40% of the cases, and the metastasis despite the early diagnosis was detected in 50% of cases.
💡
Conclusion & Impact:As in our study, in retrospective studies involving old ages and not enough sampling, tumor diameter may be used as an alternative prognostic factor for pathological staging in tumors with a stage above pT2.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The renal cell carcinoma (RCC), which is the most frequently seen malign renal tumor, consists of 2-4% of all the malign tumors seen among adult individuals and 80-90% of all the malign renal tumors. The recurrence is seen in 40% of the cases, and the metastasis despite the early diagnosis was detected in 50% of cases. In present study, it was aimed to distribution of renal tumors in our hospital, discuss the prognostic factors such as the, pathological stage, nuclear grade and tumor diameter accompanied by literature information. Patients and Methods: By retrospectively scanning the records of Pathology Department of Medical Faculty, Fırat University, for the period between 1988 and 2009, 140 renal tumor cases were determined and the previous diagnoses, histological degrees, pathological stages of these cases were evaluated and the final diagnoses were taken as base in the present study. In pathologically staging (pT) of RCCs, TNM classification was used, whereas Fuhrman nuclear grading (FNG) was used in nuclear grading procedure. The patients were divided into different groups based on their genders and ages. Results: When compared to the literature in terms of the mean age, the present study involves relatively young population (mean age 57), and the majority was male (male/ female:1.1). In the present study, the RCCs with largest diameter were papillary type (9,78cm) ones, whereas the RCCs with lowest diameter values were classic type. A statistically significant relationship was observed between the benign, borderline and malign tumor diagnoses and diameters (p= 0.023). It was determined that approximately one-four of RCC cases were in highly pathological stage (21,6%, pT3a-3b). A direct proportional and statistically significant relationship was found between nuclear grade and diameter (p=0,002). Conclusion: Pathological stage, nuclear grade and diameter are the leading factors affecting the prognosis. As in our study, in retrospective studies involving old ages and not enough sampling, tumor diameter may be used as an alternative prognostic factor for pathological staging in tumors with a stage above pT2.

Özet

Amaç: En sık görülen malign böbrek tümörü olan renal hücreli karsinom (RCC), yetişkinlerde görülen tüm malign tümörlerin %2-4’ünü, tüm malign böbrek tümörlerinin ise %80-90’inini oluşturur. Bu çalışmada hastanemizdeki renal tümörlerin dağılımı, patolojik evreleme, nükleer derece ve tümör çapı gibi prognostik faktörlerin literatür bilgileri eşliğinde tartışılması amaçlanmıştır. Hastalar ve Yöntem: Fırat Üniversitesi Tıp Fakültesi Patoloji Anabilim Dalında 1988-2009 yılları arasında retrospektif olarak 140 böbrek tümörü saptandı ve bu tümörlerin daha önceki tanıları, histolojik dereceleri ve patolojik evreleri yeniden değerlendirildi, son tanıları çalışmada esas alındı. RCC’ların patolojik evreleme (pT)’de TNM sınıflaması ve nükleer derecelendirme (grade)’de Fuhrman nükleer derecelendirme (FND) sistemi kullanıldı. Hastaların cinsiyetleri ve yaş aralıklarına göre farklı alt gruplara ayrıldı. Bulgular: Çalışmamızda ortalama yaş genel literatürden nispeten genç bir popülasyonu (ortalama yaş 57) içermekte ve erkek baskınlığı (erkek /kadın:1,1) göstermektedir. Çalışmadaki RCC'lar arasında en büyük çapa sahip olan papiller tip (9.78cm), en küçük çapa sahip olan ise klasik tipti. Benign, borderline ve malign tümör tanıları ile çaplar arasında ise istatistiksel olarak anlamlı ilişki saptandı (p= 0.023). RCC vakalarının yaklaşık dörte birinin (%21,6, pT3a-3b) yüksek patolojik evreli olduğu görüldü. Artan nükleer derece ile çap arasında doğru orantı ve istatistiksel olarak anlamlı bir ilişki izlendi (p=0,002). Sonuç: Prognozu etkileyen faktörlerin başında patolojik evre, nükleer derece ve çap yer almaktadır. Bizim çalışmamızda da olduğu gibi eski yılları içeren ve örneklemesi yeterli düzeyde yapılmayan retrospektif çalışmalarda özellikle pT2’nin üzerinde evreye sahip tümörlerde tümör çapı patolojik evrelemeye alternatif bir prognostik faktör olarak kullanılabilir.

🔖

Cite This Article

KÜÇÜK, Ş., AKPOLAT, N. (2022). The Distribution of Kidney Tumors in Our Hospital, The Relationship Between Pathological Stage, Nuclear Grade and Tumor Diameter: Analysis of 140 Cases. Selçuk Tıp Dergisi, Cilt: 35 - Sayı: 2, 105–112. https://ajindex.com/articles/591859

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Bonsib SM. Neoplastik disease of the kidney. In: Bostwick DG. Eble JN (ed.) Urologic Surgical Pathology. 2. edition, Canada: Mosby, 2001;4-81
  2. Reuter VE, Tickoo SK. Adult Renal Tumors. In: Carter D, Greenson JK. Oberman HA, Reuter V. Stoler MH (ed.) Sternberg’s Diagnostic Surgical Pathology. 4. edition, Philadelphia Lippincott Williams & Wilkins, 2004;1955-2001
  3. Eble JN, Sauter G, Epstein JI, et al. Tumors of kidney. Tumors of the urinary system and male genital organs. In World Health Organization Classification of tumors. 4. edition IARC press: 2016;11-76
  4. Mohammadian M, Pakzad R, Towhidi F, et al. Incidence and mortality of kidney cancer and its relationship with HDI (Human development index) in the world in 2012. Clujul Medical 2017;90 (3):286-93
  5. Mahasin SZ, Aloudah N, Al-Surimi K, et al. Epidemiology profile of renal cell carcinoma: A 10-year patients' experience at King Abdulaziz Medical City, National Guard Health Affairs, Saudi Arabia. Urol Ann 2018;10(1):59-64
  6. Mikami S, Oya M, Mizuno R, et al. Recent advances in renal cell carcinoma from a pathological point of view. Pathology International 2016;66:481-90
  7. Casuscellia J, Vanob YN, Fridmanc WH, et al. Molecular classification of renal cell carcinoma and its implication in future clinical practice. Kidney Cancer 2017;1(1):3-13
  8. Nabi S, Kessler ER, Bernard B, et al. Renal cell carcinoma: A review of biology and pathophysiology. F1000Research 2018;307 (7):1-10
  9. Kentaro Inamura. Renal cell tumors: Understanding their molecular pathological epidemiology and the 2016 WHO Classification. Int J Mol Sci 2017;2195(18):2-15
  10. Muglia VF, Prando A. Renal cell carcinoma: Histological classification and correlation with imaging findings. Radiol Bras 2015;48(3):166-74
  11. Chaan SNg, Wood CG, Silverman PM, et al. Renal cell carcinoma: Diagnosis, staging, and surveillance. AJR 2008;191:1220-32
  12. Escudier B, Porta C, Schmidinge M. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2016;27(5):58-68
  13. Sandlund J, Oosterwijk E, Grankvit K, et al. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma. Journal Compilation 2007;100:556-60
  14. Abdel-Rahman O. Impact of histological subtype on outcomes of renal cell carcinoma patients. Journal of Drug Assesment. 2018;7(1):14-20
  15. Comperat E, Camparo P. Histological classification of malignant renal tumours at a time of major diagnostic and